180 related articles for article (PubMed ID: 23060147)
1. SAMNet: a network-based approach to integrate multi-dimensional high throughput datasets.
Gosline SJ; Spencer SJ; Ursu O; Fraenkel E
Integr Biol (Camb); 2012 Nov; 4(11):1415-27. PubMed ID: 23060147
[TBL] [Abstract][Full Text] [Related]
2. Albumin-induced epithelial-mesenchymal transition and ER stress are regulated through a common ROS-c-Src kinase-mTOR pathway: effect of imatinib mesylate.
Lee JY; Chang JW; Yang WS; Kim SB; Park SK; Park JS; Lee SK
Am J Physiol Renal Physiol; 2011 May; 300(5):F1214-22. PubMed ID: 21367918
[TBL] [Abstract][Full Text] [Related]
3. Quantitative- and phospho-proteomic analysis of the yeast response to the tyrosine kinase inhibitor imatinib to pharmacoproteomics-guided drug line extension.
Dos Santos SC; Mira NP; Moreira AS; Sá-Correia I
OMICS; 2012 Oct; 16(10):537-51. PubMed ID: 22775238
[TBL] [Abstract][Full Text] [Related]
4. SAMNetWeb: identifying condition-specific networks linking signaling and transcription.
Gosline SJ; Oh C; Fraenkel E
Bioinformatics; 2015 Apr; 31(7):1124-6. PubMed ID: 25414365
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
[TBL] [Abstract][Full Text] [Related]
6. Epithelial Mesenchymal Transition in Aggressive Lung Cancers.
Mittal V
Adv Exp Med Biol; 2016; 890():37-56. PubMed ID: 26703798
[TBL] [Abstract][Full Text] [Related]
7. Integration of pan-cancer transcriptomics with RPPA proteomics reveals mechanisms of epithelial-mesenchymal transition.
Koplev S; Lin K; Dohlman AB; Ma'ayan A
PLoS Comput Biol; 2018 Jan; 14(1):e1005911. PubMed ID: 29293502
[TBL] [Abstract][Full Text] [Related]
8. Alisertib inhibits migration and invasion of EGFR-TKI resistant cells by partially reversing the epithelial-mesenchymal transition.
Wang CY; Lee MH; Kao YR; Hsiao SH; Hong SY; Wu CW
Biochim Biophys Acta Mol Cell Res; 2021 May; 1868(6):119016. PubMed ID: 33744274
[TBL] [Abstract][Full Text] [Related]
9. High EMT Signature Score of Invasive Non-Small Cell Lung Cancer (NSCLC) Cells Correlates with NFκB Driven Colony-Stimulating Factor 2 (CSF2/GM-CSF) Secretion by Neighboring Stromal Fibroblasts.
Rudisch A; Dewhurst MR; Horga LG; Kramer N; Harrer N; Dong M; van der Kuip H; Wernitznig A; Bernthaler A; Dolznig H; Sommergruber W
PLoS One; 2015; 10(4):e0124283. PubMed ID: 25919140
[TBL] [Abstract][Full Text] [Related]
10. The regulatory role of APE1 in epithelial-to-mesenchymal transition and in determining EGFR-TKI responsiveness in non-small-cell lung cancer.
Yang X; Peng Y; Jiang X; Lu X; Duan W; Zhang S; Dai N; Shan J; Feng Y; Li X; Cheng Y; Yang Y; Baugh L; Tell G; Wang D; Li M
Cancer Med; 2018 Sep; 7(9):4406-4419. PubMed ID: 30109782
[TBL] [Abstract][Full Text] [Related]
11. [Effect of tyrosine kinase inhibitor imatinib mesylate on K562 cell invasion by PTEN pathway].
Cheng ZY; Liang WT; Yan XY; Wan JS; Bian YS; Bai P; Liang LQ; Jie JQ; Li AM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Nov; 28(11):1129-32. PubMed ID: 23127398
[TBL] [Abstract][Full Text] [Related]
12. Tumor-suppressive effects of microRNA-181d-5p on non-small-cell lung cancer through the CDKN3-mediated Akt signaling pathway in vivo and in vitro.
Gao LM; Zheng Y; Wang P; Zheng L; Zhang WL; Di Y; Chen LL; Yin XB; Tian Q; Shi SS; Xu SF
Am J Physiol Lung Cell Mol Physiol; 2019 May; 316(5):L918-L933. PubMed ID: 30628487
[TBL] [Abstract][Full Text] [Related]
13. Epithelial-Mesenchymal Transition Predicts Polo-Like Kinase 1 Inhibitor-Mediated Apoptosis in Non-Small Cell Lung Cancer.
Ferrarotto R; Goonatilake R; Yoo SY; Tong P; Giri U; Peng S; Minna J; Girard L; Wang Y; Wang L; Li L; Diao L; Peng DH; Gibbons DL; Glisson BS; Heymach JV; Wang J; Byers LA; Johnson FM
Clin Cancer Res; 2016 Apr; 22(7):1674-1686. PubMed ID: 26597303
[TBL] [Abstract][Full Text] [Related]
14. Kinase switching in mesenchymal-like non-small cell lung cancer lines contributes to EGFR inhibitor resistance through pathway redundancy.
Thomson S; Petti F; Sujka-Kwok I; Epstein D; Haley JD
Clin Exp Metastasis; 2008; 25(8):843-54. PubMed ID: 18696232
[TBL] [Abstract][Full Text] [Related]
15. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
16. Cyclic pentapeptide cRGDfK enhances the inhibitory effect of sunitinib on TGF-β1-induced epithelial-to-mesenchymal transition in human non-small cell lung cancer cells.
Park KY; Kim J
PLoS One; 2020; 15(8):e0232917. PubMed ID: 32810161
[TBL] [Abstract][Full Text] [Related]
17. Network-Based Interpretation of Diverse High-Throughput Datasets through the Omics Integrator Software Package.
Tuncbag N; Gosline SJ; Kedaigle A; Soltis AR; Gitter A; Fraenkel E
PLoS Comput Biol; 2016 Apr; 12(4):e1004879. PubMed ID: 27096930
[TBL] [Abstract][Full Text] [Related]
18. Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGFβ-induced epithelial-to-mesenchymal transition.
Du L; Yamamoto S; Burnette BL; Huang D; Gao K; Jamshidi N; Kuo MD
Cancer Med; 2016 Aug; 5(8):1962-72. PubMed ID: 27318801
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide identification of genes required for yeast growth under imatinib stress: vacuolar H+-ATPase function is an important target of this anticancer drug.
dos Santos SC; Sá-Correia I
OMICS; 2009 Jun; 13(3):185-98. PubMed ID: 19260806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
